Semaglutide reduces the absolute risk of major cardiovascular events by 1.5%

被引：1
|
作者：
Phizackerley, David [1 ]
机构：
[1] Drug & Therapeut Bulletin, London, England
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2024年 / 384卷
关键词：
D O I：
10.1136/bmj.q53
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Semaglutide reduces risk of major cardiovascular events by 20%, finds study
    Wise, Jacqui
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 383 : p2668
  • [2] Semaglutide: no increased risk of cardiovascular events
    Reactions Weekly, 2019, 1758 (1) : 10 - 10
  • [3] Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
    Husain, Mansoor
    Bain, Stephen C.
    Jeppesen, Ole K.
    Lingvay, Ildiko
    Sorrig, Rasmus
    Treppendahl, Marianne B.
    Vilsboll, Tina
    DIABETES OBESITY & METABOLISM, 2020, 22 (03): : 442 - 451
  • [4] LOW ABSOLUTE RISK OF THROMBOTIC AND MAJOR CARDIOVASCULAR EVENTS IN OUTPATIENT PREGNANT WOMEN WITH COVID-19
    Bikdeli, Behnood
    Krishnathasan, Darsiya
    Lan, Zhou
    Bejjani, Antoine
    Khairani, Candrika D.
    Davies, Julia
    Porio, Nicole
    Campia, Umberto
    Almarzooq, Zaid
    Nauffal, Victor
    Wei, Eric
    Achanta, Aditya
    Ortiz-Rios, Marcos
    Jesudasen, Sirus
    Merli, Geno J.
    Leiva, Orly
    Rizzo, Samantha
    Pfeferman, Mariana
    Vishnevsky, Alec
    Hsia, Judith A.
    Bonaca, Marc P.
    Carroll, Brett
    Goldhaber, Samuel Z.
    Piazza, Gregory
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2329 - 2329
  • [5] Aspirin reduces risk of cardiovascular events, increases risk of bleeding
    不详
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2006, 73 (04) : 368 - 368
  • [6] Semaglutide consistently reduces cardiovascular events in both male and female subjects with type 2 diabetes
    Hramiak, I.
    DeSouza, C.
    Seufert, J.
    Hansen, T.
    Pettersson, J.
    Thielke, D.
    Lingvay, I.
    DIABETOLOGIA, 2018, 61 : S357 - S357
  • [7] Semaglutide Consistently Reduces Cardiovascular Events in Both Male and Female Subjects with Type 2 Diabetes
    Hramiak, Irene
    Desouza, Cyrus
    Seufert, Jochen
    Hansen, Thomas
    Thielke, Desiree
    Lingvay, Ildiko
    DIABETES, 2018, 67
  • [8] Once-weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysis
    Kobo, Ofer
    Cavender, Matthew A.
    Jensen, Thomas Jon
    Kuhlman, Anja Birk
    Rasmussen, Soren
    Verma, Subodh
    DIABETES OBESITY & METABOLISM, 2024, 26 (03): : 1129 - 1132
  • [9] Oral thrombin inhibitor reduces major cardiovascular events following MI
    不详
    FORMULARY, 2003, 38 (10) : 577 - +
  • [10] Role of the "resistin pathway" on cardiovascular risk factors and major cardiovascular events
    Menzaghi, C.
    Marucci, A.
    Antonucci, A.
    De Bonis, C.
    Ortega-Moreno, L.
    Salvemini, L.
    Copetti, M.
    Tischitta, V.
    Di Paola, R.
    DIABETOLOGIA, 2016, 59 : S512 - S513
12345